153 related articles for article (PubMed ID: 33797362)
1. Chemotherapeutic Strategies for Combating Staphylococcus aureus Infections.
Sharma N; Chhillar AK; Dahiya S; Punia A; Choudhary P; Gulia P; Behl A; Dangi M
Mini Rev Med Chem; 2022; 22(1):26-42. PubMed ID: 33797362
[TBL] [Abstract][Full Text] [Related]
2. P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections.
Gupta R; Prasad Y
Curr Microbiol; 2011 Jul; 63(1):39-45. PubMed ID: 21519800
[TBL] [Abstract][Full Text] [Related]
3. Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review.
Gopikrishnan M; Haryini S; C GPD
J Basic Microbiol; 2024 May; 64(5):e2300579. PubMed ID: 38308076
[TBL] [Abstract][Full Text] [Related]
4. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Drug Resistance of
Luan W; Liu X; Wang X; An Y; Wang Y; Wang C; Shen K; Xu H; Li S; Liu M; Yu LU
Pol J Microbiol; 2019 Dec; 68(4):477-491. PubMed ID: 31880892
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal mutations involved in antibiotic resistance in Staphylococcus aureus.
Espedido BA; Gosbell IB
Front Biosci (Schol Ed); 2012 Jan; 4(3):900-15. PubMed ID: 22202098
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications of lysostaphin against Staphylococcus aureus.
Jayakumar J; Kumar VA; Biswas L; Biswas R
J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154
[TBL] [Abstract][Full Text] [Related]
9. Development of Advanced Chimeric Endolysin to Control Multidrug-Resistant
Lee C; Kim J; Son B; Ryu S
ACS Infect Dis; 2021 Aug; 7(8):2081-2092. PubMed ID: 34047546
[TBL] [Abstract][Full Text] [Related]
10. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus.
Assis LM; Nedeljković M; Dessen A
Drug Resist Updat; 2017 Mar; 31():1-14. PubMed ID: 28867240
[TBL] [Abstract][Full Text] [Related]
11. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
Schmelcher M; Powell AM; Becker SC; Camp MJ; Donovan DM
Appl Environ Microbiol; 2012 Apr; 78(7):2297-305. PubMed ID: 22286996
[TBL] [Abstract][Full Text] [Related]
12. Exploring the therapeutic potential of staphylococcal phage formulations: Current challenges and applications in phage therapy.
Khullar L; Harjai K; Chhibber S
J Appl Microbiol; 2022 May; 132(5):3515-3532. PubMed ID: 35064991
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.
Haddad Kashani H; Schmelcher M; Sabzalipoor H; Seyed Hosseini E; Moniri R
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187396
[No Abstract] [Full Text] [Related]
14. Lysostaphin: an antistaphylococcal agent.
Kumar JK
Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against
Esteban P; Redrado S; Comas L; Domingo MP; Millán-Lou MI; Seral C; Algarate S; Lopez C; Rezusta A; Pardo J; Arias M; Galvez EM
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33498622
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
17. Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection.
Kim NH; Park WB; Cho JE; Choi YJ; Choi SJ; Jun SY; Kang CK; Song KH; Choe PG; Bang JH; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038042
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
Polak J; Della Latta P; Blackburn P
Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
[TBL] [Abstract][Full Text] [Related]
19. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
20. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
Cameron DR; Howden BP; Peleg AY
Clin Infect Dis; 2011 Sep; 53(6):576-82. PubMed ID: 21865195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
